endothelium
commun
endotheli
cell
ec
line
blood
lymphat
vessel
thu
form
interfac
tissu
blood
lympha
strateg
posit
endothelium
infer
indispens
function
role
control
vasoregul
haemostasi
inflamm
state
endothelium
simultan
caus
effect
mani
diseas
coupl
modif
endotheli
phenotyp
repres
marker
biochem
profil
blood
repres
biomark
paper
briefli
review
data
function
role
endothelium
give
definit
endotheli
marker
biomark
touch
methodolog
approach
reveal
biomark
present
implicit
role
endothelium
toxicolog
mechanist
studi
survey
role
reactiv
oxygen
speci
ro
modul
endotheli
statu
volum
public
role
endothelium
health
diseas
increas
exponenti
last
decad
may
seem
problem
thoroughli
consid
plethora
excel
review
subject
newcom
refer
reliabl
sourc
detail
inform
present
paper
endothelium
monolay
endotheli
cell
ec
line
interior
surfac
blood
vessel
lymphat
vessel
heart
chamber
natur
blood
contain
larg
surfac
human
ec
form
diffus
tissu
weigh
around
g
adult
larg
proport
g
cover
surfac
capillari
microvessel
brain
repres
brain
compart
constitut
signific
length
ca
mile
surfac
exchang
ca
blood
parenchyma
brain
earli
stage
gastrul
vertebr
embryo
produc
ec
mesoderm
first
juvenil
ec
form
primit
vascular
plexu
de
novo
later
differenti
arteri
venou
lymphat
capillari
ec
vasculogenesi
heart
five
distinct
ec
type
endocardi
coronari
arteri
venou
capillari
lymphat
correspond
phenotyp
found
passag
plasma
molecul
cell
blood
surround
tissu
normal
regul
semiperm
barrier
form
ec
exchang
nutrient
respiratori
regulatori
molecul
occur
capillari
ratio
endotheli
surfac
blood
volum
arteri
vein
vesseland
tissuespecif
function
ec
interact
blood
cell
molecul
relat
differ
parenchym
smooth
muscl
cell
blood
oxygen
shear
forc
blood
flow
exampl
arteri
white
plateletrich
thrombi
form
vein
fibrin
red
addit
vein
contain
valv
often
becom
initi
site
venou
thrombosi
microvascular
ec
specif
phenotyp
blood
vessel
differ
organ
surround
tissu
wellstudi
endotheli
morpholog
phenotyp
continu
bloodbrain
barrier
fenestr
exocrin
endocrin
gland
gastric
intestin
mucosa
choroid
plexu
glomeruli
subpopul
renal
tubul
sinusoid
discontinu
liver
spleen
bone
marrow
ec
bloodbrain
barrier
bbb
form
continu
layer
tight
junction
cell
lack
fenestra
sustain
low
rate
transcytosi
significantli
limit
paracellular
transcellular
exchang
molecul
also
ec
bbb
low
express
leukocyt
adhes
molecul
make
imposs
immun
cell
penetr
healthi
cn
interestingli
alkalin
phosphatas
characterist
featur
bbb
phenotyp
differenti
capillari
ec
brain
peripheri
moreov
tissuespecif
express
ggt
monoamin
oxidas
mao
also
found
ec
brain
microvessel
contrari
thrombomodulin
absent
poorli
express
brain
microvascular
liver
sinusoid
ec
abundantli
present
ec
mani
tissu
beyond
bbb
transfer
macromolecul
across
endothelium
transcytosi
transcellular
rout
mediat
caveola
vesiculovacuolar
organel
vvo
transendotheli
channel
densiti
caveola
capillari
endothelium
may
amount
per
cell
greatli
exce
arteri
arteriol
vein
venul
transport
fluid
small
solut
occur
cell
paracellular
rout
clathrinco
pit
promin
liver
sinusoid
endothelium
involv
endocytosi
bone
marrow
ec
express
eselectin
constitut
wherea
type
ec
produc
express
eselectin
upon
inflammatori
activ
respons
inflammatori
cytokin
vasoact
agent
differ
variou
vessel
rule
postcapillari
venul
respons
highli
pronounc
ec
small
muscular
arteri
arteriol
display
high
angiotensinconvert
enzym
ace
immunoreact
organ
studi
except
kidney
ec
larg
arteri
vein
poorli
reactiv
complet
neg
healthi
endothelium
character
vasodilatori
phenotyp
high
level
nitric
oxid
prostacyclin
pgi
low
level
uric
acid
reactiv
oxygen
speci
ro
hand
ec
involv
aetiolog
major
human
diseas
stroke
diabet
insulin
resist
heart
diseas
peripher
vascular
diseas
tumor
growth
metastasi
chronic
kidney
failur
rheumatoid
arthriti
viral
infect
quiescent
state
ec
express
mhc
major
histocompat
class
molecul
prr
patternrecognit
receptor
detect
pamp
pathogenassoci
molecular
pattern
inflammatori
stimuli
trigger
transform
ec
proinflammatori
procoagulatori
state
respons
inflammatori
stimuli
risk
factor
ec
express
mhc
ii
molecul
present
endotheli
antigen
immun
cell
increas
express
endotheli
marker
cell
adhes
molecul
cam
applic
ro
proinflammatori
stimuli
also
describ
larg
amount
ro
neg
impact
endotheli
cell
wherea
low
concentr
ro
signal
function
perman
produc
cell
imbal
ro
product
neutral
lead
vascular
remodel
possibl
sourc
ro
within
endotheli
andor
neighbour
cell
includ
nadph
oxidas
mitochondria
xanthin
oxidas
synthas
cytochrom
lipoxygenas
cyclooxygenas
peroxidas
monoamin
oxidas
hemoglobin
erythrocyt
spite
extens
studi
impress
result
still
need
better
understand
dynam
chang
endotheli
marker
biomark
associ
differ
disord
also
littl
known
role
endothelium
field
toxicolog
intox
organophosph
hydrocarbon
forth
gap
understand
immedi
delay
respons
endothelium
role
ro
respons
would
interest
reveal
interrel
feedback
feedforward
regulatori
effect
variou
sourc
ro
develop
vascular
patholog
final
great
challeng
exist
methodolog
biomark
discoveri
concern
instrument
comput
approach
review
discuss
problem
could
help
reestim
old
data
well
reveal
someth
new
futur
cell
surfac
marker
protein
express
surfac
cell
often
serv
marker
specif
cell
type
von
willebrand
factor
vwf
togeth
weibelpalad
bodi
wpb
angiotensinconvert
enzym
ace
cobbleston
morpholog
specif
monolay
cultur
previous
refer
oblig
criteria
confirm
authent
puriti
endotheli
cell
cultur
modern
though
exhaust
list
endotheli
marker
characterist
short
given
tabl
howev
first
design
endotheli
marker
still
scrupul
attent
mani
research
great
progress
made
reveal
role
structur
mechanist
pathway
regul
princip
marker
endothelium
weibelpalad
bodi
specif
endotheli
organel
contain
vwf
pselectin
particip
platelet
bind
leukocyt
recruit
modul
inflamm
respect
vwf
import
compon
haemostasi
bind
platelet
site
endotheli
damag
produc
megakaryocyt
ec
vwf
found
huvec
tabl
endotheli
cell
marker
modifi
http
wwwrndsystemscomresearchareaendothelialcellmark
n
transmembran
peptidas
induc
vasculatur
solid
tumor
potent
angiogen
regul
function
novel
modul
signal
transduct
cell
motil
via
influenc
specif
plasma
membran
organ
thu
regul
angiogenesi
integrin
particip
endotheli
sprout
though
neg
regul
prolifer
ec
matur
vessel
integrin
need
proper
local
vecadherin
cellcel
junction
integr
requir
format
nonleaki
blood
vessel
integrin
necessari
interact
cardiomyocyt
endotheli
cell
thu
regul
cardiac
myocyt
reorgan
known
plateletendotheli
cell
adhes
molecul
heavili
glycosyl
transmembran
homophil
adhes
protein
highli
express
endotheli
cell
requir
migrat
leukocyt
play
key
role
remov
age
neutrophil
bodi
extracellular
domain
releas
endotheli
cell
apoptosi
fragment
circul
serum
patient
suffer
myocardi
infarct
acut
ischem
stroke
multipl
sclerosi
transmembran
phosphoglycoprotein
first
identifi
hematopoiet
stem
progenitor
cell
cell
express
found
umbil
cord
bone
marrow
endotheli
progenitor
cell
subset
mesenchym
stem
cell
hematopoiet
cell
ec
blood
vessel
pleural
lymphat
vessel
presenc
nonhematopoiet
cell
variou
tissu
link
progenitor
adult
stem
cell
phenotyp
known
scaveng
receptor
class
b
member
thrombospondin
receptor
collagen
receptor
platelet
membran
glycoprotein
iv
gpiv
gpiiib
fatti
acid
translocas
fat
upon
ligand
bind
transduc
signal
mediat
wide
rang
proinflammatori
cellular
respons
exampl
activ
innat
immun
receptor
lead
product
superoxid
anion
via
nadph
oxidas
ectonucleotidas
abundantli
express
surfac
ec
lesser
degre
surfac
platelet
leukocyt
catal
extracellular
dephosphoryl
atp
adp
amp
molecul
liber
coronari
vascular
endothelium
ischemiareperfus
level
circul
ectonucleotidas
may
reflect
sever
ischem
vascular
injuri
attenu
lack
activ
associ
vascular
dysfunct
remodel
pulmonari
arteri
hypertens
decreas
hepat
regener
failur
vascular
reconstitut
express
endotheli
colonyform
cell
ecfc
regul
neurovascular
trophic
effect
ecfc
adult
endotheli
progenitor
cell
epc
differenti
particip
regener
ec
resid
vasculatur
migrat
place
injuri
form
circul
ec
ecfc
play
import
role
vascular
heal
injuri
development
angiogenesi
interestingli
overexpress
stabil
cystineglutam
antiport
increas
cystein
gsh
level
cancer
stem
cell
endotheli
molecul
particip
intracellular
calcium
mobil
increas
permeabl
activ
src
brain
microvascular
ec
activ
signal
pathway
result
cytoskeleton
reorgan
cadherin
phosphoryl
necessari
step
tcell
transendotheli
migrat
overlap
effect
suggest
involv
differ
step
diapedesi
process
intercellular
adhes
transmembran
protein
upregul
endotheli
epitheli
cell
site
inflamm
mediat
vascular
adhes
paracellular
migrat
leukocyt
activ
solubl
particip
angiogenesi
indic
ec
activ
damag
elev
level
solubl
link
oxid
stress
hypertens
cardiovascular
diseas
type
diabet
organ
transplant
dysfunct
increas
abdomin
fat
mass
liver
diseas
certain
malign
sepsi
protein
take
part
platelet
aggreg
consid
long
time
marker
kind
cell
found
endotheli
cell
surfac
bound
protein
particular
disulfid
isomeras
eselectin
endotheli
leukocyt
adhes
one
three
member
selectin
famili
eselectin
lselectin
pselectin
transient
express
ec
respons
also
known
padgem
transmembran
adhes
protein
upregul
activ
platelet
vascular
endotheli
cell
pselectin
mediat
initi
interact
circul
leukocyt
activ
endotheli
cell
produc
characterist
roll
leukocyt
endothelium
therefor
critic
leukocyt
extravas
site
inflamm
leukocyt
involv
thrombu
format
site
vascular
injuri
exampl
hepat
sinusoid
ec
abil
express
costimulatori
adhes
molecul
express
increas
ischemiareperfus
rat
liver
also
molecul
upregul
glomerular
peritubular
ec
ischemiareperfus
also
known
collectin
receptor
antigen
type
transmembran
glycoprotein
found
ec
also
hematopoiet
progenitor
cell
platelet
cell
myeloid
origin
molecul
mediat
phagocytosi
monocyt
macrophag
upon
interact
solubl
defens
collagen
mbl
spa
receptor
tyrosin
kinas
activ
bind
stem
cell
factor
marker
certain
type
hematopoiet
progenitor
bone
marrow
hematopoiet
stem
cell
multipot
progenitor
common
myeloid
progenitor
also
express
distinguish
featur
hemogen
ec
rel
nonbloodform
ec
ri
ri
also
known
type
receptor
transmembran
protein
r
tir
superfamili
ri
bind
pleiotrop
cytokin
plu
receptor
antagonist
ra
signal
transduct
requir
complex
format
r
complex
recruit
adaptor
protein
initi
signal
pathway
ri
express
predominantli
cell
fibroblast
ec
mediat
acut
phase
inflammatori
respons
includ
fever
thrombomodulin
thrombomodulin
tm
also
known
transmembran
express
vascular
ec
arteri
smooth
muscl
cell
monocyt
macrophag
bind
thrombin
enhanc
thrombinmedi
activ
anticoagul
protein
c
antifibrinolyt
taficarboxypeptidas
thrombomodulin
also
inhibit
abil
thrombin
activ
sever
procoagul
protein
eg
fibrinogen
factor
v
factor
xiii
solubl
fragment
thrombomodulin
elev
serum
urin
synovi
fluid
coagul
disord
inflamm
organ
failur
tissu
factor
integr
membran
protein
shown
produc
sever
cell
type
includ
ec
serv
cofactor
coagul
factor
vii
ace
cell
surfac
proteas
maintain
blood
pressur
homeostasi
fluid
salt
balanc
mainli
due
gener
angiotensin
ii
inactiv
bradykinin
also
ace
activ
play
role
immun
reproduct
neuropeptid
regul
vascular
endotheli
cadherin
specif
endotheli
adhes
molecul
locat
junction
ec
vecadherinmedi
adhes
import
control
vascular
permeabl
leukocyt
extravas
also
vecadherin
particip
cell
prolifer
apoptosi
modul
vascular
endotheli
growth
factor
receptor
function
hand
mcam
advers
prognost
factor
uterin
sarcoma
antigen
oka
blood
group
antigen
specif
epitop
protein
basigin
also
known
emmprin
tetraspanin
superfamili
glycoprotein
express
ec
epitheli
cell
megakaryocyt
platelet
interact
tetraspanin
integrin
play
role
cellular
adhes
migrat
platelet
activ
gpianchor
glycoprotein
one
iglik
vtype
domain
found
mainli
subpopul
cytolyt
cell
nk
cell
serv
receptor
mhc
class
relat
molecul
express
ec
play
role
antiangiogen
signal
apoptot
cell
death
epcr
endotheli
protein
c
receptor
transmembran
glycoprotein
express
ec
epcr
inhibit
thrombosi
interact
protein
c
activ
protein
c
apc
coagul
factor
vii
viia
enhanc
activ
protein
c
respons
complex
thrombinthrombomodulin
solubl
form
epcr
inhibit
anticoagul
activ
apc
epcr
bind
monocyt
mediat
monocyt
adhes
vascular
endothelium
addit
bind
antigen
receptor
gammadelta
cell
promot
hematopoiet
stem
cell
retent
bone
marrow
contribut
malaria
pathogen
bind
surfac
protein
plasmodium
alpha
two
member
type
subfamili
type
cytokin
receptor
also
serv
receptor
bind
r
also
known
low
affin
form
high
affin
receptor
togeth
r
alpha
chain
caus
downstream
activ
hand
bind
r
alpha
high
affin
subsequ
product
though
without
activ
endosialin
also
known
tumor
endotheli
marker
kda
transmembran
oglycosyl
protein
contain
one
ctype
lectin
one
sushi
one
egflik
domain
mucinlik
stalk
extracellular
domain
ecd
express
activ
perivascular
stromal
cell
embyron
tumor
neovasculatur
downregul
quiescent
vasculatur
endosialin
regul
pericyt
prolifer
migrat
adhes
matrix
fibronectin
collagen
iv
vascular
endotheli
growth
factor
receptor
transmembran
receptor
tyrosin
kinas
mediat
angiogen
effect
vegfa
vegfc
express
primarili
vascular
ec
endotheli
cell
progenitor
also
express
endometri
epithelium
hematopoiet
stem
cell
liver
sinusoid
ec
sertoli
cell
leydig
cell
platelet
megakaryocyt
sensori
autonom
neuron
schwann
cell
muller
glial
cell
retin
progenitor
osteoblast
increas
express
lead
increas
endotheli
permeabl
microvascular
bed
adam
disintegrin
metalloproteinas
serv
princip
regul
cytokin
growth
factor
adhes
molecul
proteolyt
shed
cell
surfac
adam
express
ec
respons
impair
vascular
barrier
hypoxia
possibl
proteolysi
tight
junction
molecul
ec
membran
disintegrinlik
metalloproteas
thrombospondin
type
zinccontain
metalloproteas
enzym
cleav
von
willebrand
factor
produc
liver
stellat
cell
ec
present
platelet
also
produc
kidney
podocyt
subsequ
deposit
glomerular
basement
membran
thu
prevent
clot
format
ec
major
contribut
bulk
product
bodi
member
disintegrin
metalloproteinas
thrombospondin
motif
adamt
famili
proteas
particip
angiogenesi
coagul
dysregul
enzym
lead
inflamm
cancer
arthriti
atherosclerosi
diseas
endotheli
cell
secret
enhanc
thrombin
platelet
aggreg
destroy
ctermin
fragment
transmembran
cxc
chemokin
ligand
eryptot
erythrocyt
adher
ec
vascular
wall
part
interact
phosphatidylserin
expos
erythrocyt
surfac
endotheli
discoidin
cub
lccl
domain
contain
also
known
esdn
endotheli
smooth
muscl
cellderiv
neuropilinlik
structur
similar
neuropilin
vegf
receptor
semaphorin
particip
cell
motil
metastasi
endomucin
endomucin
endotheli
sialomucin
also
kda
glycoprotein
member
endomucin
famili
protein
express
ec
function
either
proor
antiadhes
molecul
depend
glycosyl
pattern
esam
esam
endotheli
cellselect
adhes
molecul
ecassoci
member
ctx
subgroup
ig
superfamili
associ
tight
adheren
junction
also
modul
transendotheli
cell
migrat
along
fatti
acidbind
protein
fabp
small
cytoplasm
lipidbind
protein
bind
free
fatti
acid
cholesterol
retinoid
involv
intracellular
transport
lipid
along
biomark
circul
fabp
use
indic
tissu
damag
hypoxia
affect
express
fabp
ec
igg
huvec
behav
igproduc
immun
cell
stimulu
extern
igg
secretori
pathway
also
activ
huvec
togeth
express
fcrn
associ
newli
synthes
igg
thu
form
complex
secret
integrin
integrin
ensur
close
intercellular
adhes
ec
pericyt
requir
blood
vessel
format
integrin
express
prolifer
ec
express
prolifer
pericyt
antagonist
interact
block
adhes
perivascular
cell
prolifer
ec
therebi
induc
apoptosi
ec
pericyt
inhibit
neovascular
factor
transcript
factor
central
regul
sprout
angiogenesi
via
regul
notch
signal
pathway
endotheli
renoprotect
mediat
statininduc
protect
ischem
aki
regul
express
cell
adhes
molecul
concomit
recruit
inflammatori
cell
lymphat
vessel
endotheli
hyaluronan
ha
kda
type
transmembran
glycoprotein
member
link
protein
superfamili
modul
cell
behavior
exert
activ
develop
tissu
remodel
diseas
marker
lymphat
ec
also
express
hepat
sinusoid
ec
lesser
degre
found
kupffer
cell
islet
langerhan
cortic
neuron
renal
epithelium
notch
signal
evolutionari
conserv
pathway
critic
cardiovascular
develop
contribut
notch
signal
homeostasi
adult
vasculatur
emerg
novel
paradigm
suggest
pathway
sensit
environment
factor
includ
inflammatori
mediat
dietderiv
byproduct
includ
glucos
lipid
metabolit
podocalyxin
also
known
podocalyxinlik
protein
sialoglycoprotein
structur
relat
podocalyxin
abundantli
express
embryon
stem
cell
also
marker
hemangioblast
common
precursor
hematopoiet
ec
podoplanin
also
known
alpha
aggru
mucintyp
transmembran
glycoprotein
extens
oglycosyl
express
lymphat
ec
well
nonendotheli
cell
tissu
podoplanin
particip
regul
lymphat
vascular
format
platelet
aggreg
ralinteract
protein
kda
also
known
ralbind
protein
atpdepend
transport
electrophileglutathion
conjug
type
transmembran
member
famili
fasciclinlik
hyaluronan
ha
receptor
homolog
express
sinusoid
ec
macrophag
tumor
endotheli
marker
one
eight
tem
gene
product
associ
tumor
angiogenesi
capillari
morphogenesi
gene
type
transmembran
protein
extracellular
von
willebrand
factor
type
domain
member
anthrax
toxin
receptor
famili
highli
express
tumor
vasculatur
may
function
adhes
molecul
capillari
tubulogenesi
thrombospondin
domaincontain
protein
also
known
transmembran
molecul
thrombospondin
modul
tmtsp
type
transmembran
protein
kda
highli
express
hematopoiet
stem
cell
progenitor
cell
also
abundantli
express
ec
highest
express
lung
involv
regul
vasculogenesi
andor
angiogenesi
receptor
tyrosin
kinas
two
immunoglobulinlik
domain
flank
three
egflik
domain
three
fibronectin
type
iiilik
repeat
extracellular
region
split
tyrosin
kinas
domain
cytoplasm
region
receptor
essenti
regul
vascular
barrier
function
angiopoietin
princip
ligand
exert
opposit
effect
receptor
cell
popul
cultur
surfac
ec
ultralarg
vwf
multim
cut
shorter
one
metalloproteinas
bind
initi
domain
cut
individu
vwf
molecul
site
tyr
met
within
domain
activ
result
gener
smaller
globular
multim
length
becom
detach
circul
bind
cleavag
site
buri
roundup
structur
though
avail
high
fluid
shear
forc
interestingli
endotheli
vwf
involv
angiogenesi
inhibit
vwf
express
sirna
ec
caus
increas
vitro
angiogenesi
increas
prolifer
migrat
coupl
decreas
integrin
level
increas
releas
final
increas
vascular
vwfdefici
mice
note
addit
loss
vwf
ec
result
enhanc
dysfunct
angiogenesi
consist
clinic
observ
patient
vwf
diseas
vascular
malform
caus
sever
gastrointestin
bleed
angiotensinconvert
enzym
ace
ec
one
princip
member
reninangiotensin
system
ra
dipeptidyl
carboxypeptidas
convert
angiotensin
vasoconstrictor
angiotensin
ii
degrad
bradykinin
amyloid
betaprotein
averag
capillari
ec
organ
stain
ace
except
lung
kidney
lung
capillari
ec
express
ace
wherea
kidney
vasculatur
devoid
ace
contrast
man
rat
show
homogen
endotheli
express
ace
arteri
vein
renal
vessel
ace
express
low
reduc
ace
express
renal
vasculatur
may
protect
renal
circul
excess
angiotensin
ii
format
kinin
deplet
thu
maintain
renal
blood
flow
angiotensinconvert
enzym
rel
new
member
ra
drawn
attent
sinc
found
receptor
sar
coronaviru
normal
level
lung
necessari
host
combat
inflammatori
lung
diseas
main
activ
peptid
ra
includ
angiotensin
ii
ang
ii
ang
iii
ang
iv
angiotensin
ang
among
ang
ii
ang
import
health
diseas
function
effect
ang
differ
receptor
stimul
includ
vasodilat
natriuresi
antiprolifer
increas
bradykininno
nitric
oxid
system
catalyt
effici
higher
ang
ii
substrat
ang
axi
regard
counterregulatori
system
aceang
iiat
receptor
axi
also
suggest
ma
oncogen
may
function
receptor
ang
ma
axi
pathway
act
detriment
effect
reninangiotensin
system
sever
factor
akt
phosphoryl
pkc
activ
map
kinas
inhibit
seem
involv
signal
pathway
wide
distribut
intracellular
actinmodul
protein
bind
depolymer
filament
factin
inhibit
polymer
monomer
gactin
involv
transloc
actincofilin
complex
cytoplasm
nucleu
play
domin
role
ang
induc
arrest
autophagi
human
aortic
ec
vegf
receptor
contain
extracellular
segment
seven
immunoglobulinlik
domain
transmembran
segment
juxtamembran
segment
protein
kinas
domain
insert
amino
acid
residu
c
tissu
nonspecif
alkalin
phosphatas
tnap
local
ec
brain
blood
vessel
neuron
membran
induc
neuron
toxic
via
tau
dephosphoryl
function
play
role
neuron
loss
observ
alzheim
diseas
tnap
level
increas
blood
plasma
cerebrovascular
diseas
brain
injuri
tnf
tnf
rii
tumor
necrosi
factor
receptor
ii
also
known
wide
express
receptor
membraneassoci
activ
initi
proinflammatori
prosurviv
respons
via
signal
pathway
although
may
also
induc
apoptosi
cadherin
superfamili
consist
larg
number
cell
surfac
glycoprotein
cadherin
repeat
upon
ca
depend
cellcel
adhes
depend
vecadherin
major
endotheli
adhes
molecul
control
cellular
junction
blood
vessel
format
vestatin
vestatin
kda
secret
glycoprotein
member
rather
larg
famili
egflik
domaincontain
protein
vestatin
marker
embryon
ec
also
express
ec
adult
also
known
associ
klippeltrenaunay
syndrom
kt
congenit
vascular
morphogenesi
patholog
express
vascular
ec
mani
tissu
secret
thu
promot
prolifer
neighbor
ec
von
willebrand
factor
vwf
glycoprotein
particip
blood
coagul
releas
weibelpalad
bodi
wpb
ec
exhibit
bind
site
factor
viii
fviii
also
heparin
vwf
size
function
regul
proteas
disturb
function
lead
thrombot
thrombocytopen
purpura
also
endotheli
vwf
regul
angiogenesi
termin
tail
vegfa
stimul
activ
preform
dimer
autophosphoryl
activ
segment
tyrosin
follow
phosphoryl
addit
proteintyrosin
recruit
phosphotyrosinebind
protein
therebi
lead
signal
akt
src
map
kinas
pathway
blood
vessel
format
primarili
achiev
angiogenesisec
sprout
preexist
vessel
vessel
network
expand
sprout
form
new
connect
vessel
anastomosi
spatial
regul
vegfa
receptor
act
decoy
receptor
modul
activ
chief
pathway
vasculogenesi
angiogenesi
oxid
lowdens
lipoprotein
oxldl
impair
angiogenesi
via
degrad
markedli
suppress
huvec
tube
format
along
induc
apoptosi
ligand
vegfc
vegfd
involv
primarili
lymphangiogenesi
addit
vegf
receptor
pathway
angiopoietin
angpt
tie
anoth
ecspecif
ligandreceptor
signal
pathway
necessari
embryon
cardiovascular
lymphat
develop
angptti
system
also
control
postnat
angiogenesi
vascular
remodel
permeabl
maintain
vascular
homeostasi
adult
pathway
involv
mani
diseas
vasculatur
play
signific
role
cancer
sepsi
diabet
atherosclerosi
forth
mutat
signal
affect
vascular
morphogenesi
result
venou
malform
primari
congenit
glaucoma
ec
specif
enrich
express
paralog
tyrosin
phosphatas
veptp
ligand
secret
pericyt
quiescent
vasculatur
phosphoryl
tyrosin
residu
intracellular
domain
thu
promot
barrier
function
antiinflamm
inflamm
rapid
releas
wbp
upregul
transcript
take
place
simultan
excess
antagon
thu
reduc
signal
pathway
downstream
also
shown
hypoxia
enhanc
express
due
transcript
activ
pericyt
time
veptp
upregul
hypox
vascular
ec
endotheliumderiv
subsequ
neg
regul
activ
stimul
gtpase
reduc
radial
stress
fibr
via
nonmuscl
myosin
ii
independ
vecadherin
hand
also
recruit
veptp
ecec
contact
veptp
dephosphoryl
enhanc
vascular
permeabl
moreov
activ
signal
pathway
caus
phosphoryl
vecadherin
subsequ
betaarrestindepend
endocytosi
vecadherin
disassembl
ecec
junction
hand
ecec
junction
veptp
indirectli
dephosphoryl
via
mechan
downregul
vecadherin
tyrosin
phosphoryl
promot
ec
polar
lumen
format
thu
endotheli
permeabl
result
complex
interplay
angpt
vegf
receptor
vecadherin
veptp
target
veptp
stabil
blood
vessel
least
patient
wide
varieti
retin
choroid
vascular
diseas
cell
adhes
molecul
cam
make
signific
group
least
coupl
dozen
endotheli
marker
involv
homoor
heterophil
bind
cell
extracellular
matrix
repres
four
princip
protein
famili
immunoglobulin
integrin
cadherin
selectin
express
surfac
ec
includ
igg
platelet
endotheli
cell
adhes
molecul
kda
protein
wide
distribut
endothelium
hematopoieticderiv
cell
maintain
integr
blood
vessel
therefor
involv
leukocyteendothelium
interact
leukocytetransendotheli
migrat
inflamm
ec
often
present
inflamm
site
cell
bbb
involv
develop
andor
manifest
alzheim
diseas
parkinson
diseas
multipl
sclerosi
case
bacteri
mening
trauma
tumorassoci
ischemia
solubl
form
potenti
marker
possibl
target
therapi
inflamm
modul
gene
express
activ
transcript
factor
mediat
inflamm
influenc
bbb
permeabl
also
known
atpdepend
transport
electrophileglutathion
conjug
adheren
junction
princip
compon
intercellular
adhes
compris
transmembran
cadherin
form
homotyp
interact
adjac
cell
cytoplasm
catenin
link
cadherin
cytoskeleton
inflamm
promot
disassembl
adheren
junction
loss
intercellular
adhes
creat
gap
ec
diffus
small
molecul
transmigr
leukocyt
take
place
adhes
leukocyt
multipl
transmembran
proteinssuch
activ
small
gtpase
rhoa
rhog
ptk
signal
activ
src
one
princip
adhes
molecul
determin
chang
endotheli
permeabl
transendotheli
leukocyt
migrat
express
increas
activ
ec
proinflammatori
stimuli
effect
mediat
signal
pathway
involv
aktpkb
brain
ec
increas
express
observ
hour
stimulu
continu
hour
even
shortterm
applic
stimul
agent
protein
bind
integrin
leukocyt
mainli
neutrophil
easili
penetr
tissu
import
note
interact
determin
intensifi
h
gener
neutrophil
appear
necessari
condit
format
posit
feedback
vivo
ec
lose
surfac
shed
act
independ
signal
agent
support
inflammatori
process
endothelium
moreov
recycl
interact
ligand
intern
signal
transduct
lysosom
reintegr
plasma
membran
process
control
pkc
na
h
exchang
facilit
retent
andor
integr
plasma
membran
ec
thu
studi
regul
endotheli
phenotyp
princip
sign
state
endothelium
interest
hold
much
promis
exposur
mani
agent
factor
determin
phenotyp
life
span
ec
respond
within
minut
haemodynam
forc
vasoact
thrombogen
inflammatori
agent
acut
respons
follow
linear
receptormedi
cell
signal
pathway
influx
calcium
ion
activ
phosphoryl
enzym
gener
autoor
paracrin
regul
pgi
pge
h
co
etc
recruit
transport
vesicl
contain
variou
substanc
vwf
tpa
etc
plasma
membran
follow
apic
sort
andor
excret
time
ro
continu
gener
low
concentr
ec
due
transitori
hyperand
hypoglycemia
hypoxia
ischemiareperfus
receptor
signal
pathway
activ
variou
agonist
angiotensin
ii
thrombin
bradykinin
acetylcholin
histamin
pdgf
lp
induc
gener
ro
directli
mechanist
studi
field
hot
scienc
recent
year
exampl
lp
angiotensin
ii
launch
gener
ro
via
monoamin
oxidas
b
among
effector
primari
secondari
signal
agent
molecul
gener
ro
constitut
eg
nox
casual
eg
xanthin
oxidas
nosynthas
exert
nonlinear
pleiotrop
effect
becom
key
factor
blood
vessel
pathophysiolog
role
calcium
effect
hardli
overestim
mani
case
calcium
disbal
preced
rosinduc
dysfunct
ec
princip
reservoir
calcium
ion
endoplasm
reticulum
er
lysosom
golgi
apparatu
mitochondria
ec
around
kept
within
er
mitochondria
mitochondria
ec
look
like
branch
network
tight
contact
calcium
channel
er
plasma
membran
potenti
molecular
sourc
mitochondri
ro
reperfusionreoxygen
induc
calcium
oscil
influenc
state
mitochondria
enhanc
gener
ro
well
exocytosi
adhes
molecul
aggrav
state
endothelium
due
infiltr
leukocyt
gener
ro
hand
ro
activ
variou
calcium
channel
er
plasma
membran
lead
calcium
overload
ec
ryanodin
channel
channel
trp
superfamili
ec
transient
receptor
potenti
melastatin
regard
princip
channel
storeoper
entri
ion
nonselect
calcium
channel
endogen
ligand
adpribos
adpr
nicotin
acid
adenin
dinucleotid
phosphat
naadp
though
ca
ion
potenti
activ
channel
consid
sensor
oxid
stress
redox
statu
cell
activ
enhanc
probabl
cell
death
shown
extracellular
buildup
alzheim
diseas
ad
impair
endotheli
structur
function
activ
lead
intracellular
ca
overload
vasomotor
dysfunct
transduc
convert
oxid
stress
calcium
signal
play
import
role
roscoupl
diseas
hand
exogen
h
increas
ca
decreas
transmembran
electr
resist
lung
microvascular
ec
via
activ
mechan
requir
src
kinas
fyn
nevertheless
recent
estim
h
low
noncytotox
concentr
caus
elev
ca
cyt
cultur
huvec
calcium
releas
twopor
channel
endolysosom
vesicl
signific
find
estim
near
futur
occupi
one
central
place
intracellular
signal
reciproc
relat
ro
classic
second
messeng
protein
famili
protein
structur
featur
render
import
sensor
ro
redox
state
cell
variou
isoform
pkc
regul
assemblag
activ
necessari
condit
phosphoryl
subunit
phosphoryl
three
isoform
convent
classic
novel
atyp
signal
complex
activ
differ
pathophysiolog
state
neurodegen
diseas
atherosclerosi
hypertens
diabet
cancer
besid
pkc
phosphoryl
mani
kinas
map
kinas
casein
kinas
ckii
akt
kinas
srckinas
kinas
activ
phosphatid
acid
pa
last
seem
mechanist
target
rapamycin
complex
control
variou
signal
growth
factor
includ
vegf
energi
statu
amino
acid
mechan
stimuli
pa
shown
modul
mtor
activ
erk
signal
pathway
though
direct
bind
domain
mtor
also
occur
signal
vegf
receptor
render
activ
diacylglycerol
kinas
alpha
releas
nucleu
subsequ
product
pa
diacylglycerol
dag
besid
anoth
way
nox
activ
inflammatori
stimuli
like
riboflavin
kinas
rfk
engag
bind
activ
canon
signal
also
activ
nox
rfk
bound
death
domain
phox
subunit
nox
mechan
endothelium
barrier
dysfunct
may
vari
depend
activ
agent
prevail
primari
type
ro
sinc
h
stabl
speci
ro
use
experi
modif
redox
state
cell
studi
signal
toxic
effect
ro
h
produc
superoxid
anion
result
dismut
reaction
spontan
catalyz
superoxid
dismutas
sod
moreov
endotheli
cell
h
product
catalyz
nadph
oxidas
estim
concentr
endogen
intracellular
exogen
extracellular
h
amount
much
h
dosedepend
increas
endotheli
monolay
permeabl
maxim
effect
effect
cytotox
h
ec
relat
deplet
intracellular
glutathion
activ
redoxsensit
kinas
map
jnk
akt
signal
involv
increas
express
aldos
reductas
decreas
level
sirtuin
enhanc
express
activ
modifi
express
eno
deplet
protein
increas
well
dephosphoryl
activ
retinoblastoma
protein
rb
also
report
note
studi
perform
high
h
dose
mm
short
period
treatment
h
apoptosi
shown
common
form
cell
death
ec
expos
high
h
concentr
h
longer
die
exclus
via
necrosi
solv
controversi
ratio
earli
apoptosi
necrosi
huvec
cultur
close
physiolog
condit
high
cell
densiti
high
serum
content
estim
exposur
h
concentr
cell
viabil
assess
flow
cytometri
fluoresc
dye
detect
earli
apoptot
cell
detect
late
apoptot
necrot
cell
found
primari
mechan
cytotox
respons
apoptosi
critic
concentr
h
caus
cell
death
dens
monolay
lower
concentr
h
caus
death
individu
cell
howev
viabil
endotheli
cell
popul
retain
respons
calcium
activ
agonist
chang
compar
control
cell
studi
endotheli
phenotyp
noncytotox
concentr
h
found
sever
hour
exposur
h
carbachol
pma
intracellular
vwf
level
decreas
appar
due
exocytosi
wpb
content
confirm
analysi
immunofluoresc
microscopi
data
h
nontox
concentr
increas
amount
vwf
secret
huvec
control
elev
total
exposit
vwf
cell
surfac
pma
determin
progress
increas
express
ace
hour
respect
wherea
action
h
ace
express
increas
slowli
insignificantli
maxim
hour
h
applic
ace
molecul
presynthes
store
endotheli
cell
express
plasma
membran
depend
mainli
pkc
also
control
shed
ace
cell
exposur
pma
h
signific
chang
express
start
increas
even
min
pma
applic
express
increas
fivefold
h
exposur
maintain
level
h
effect
h
impress
express
pronounc
day
exposur
h
express
increas
respect
next
manifest
respons
level
express
known
increas
endotheli
permeabl
microvascular
bed
level
decreas
oxldltreat
huvec
due
overproduct
ro
coupl
apoptosi
annexin
vfitc
stain
increas
activ
experi
level
express
increas
within
h
stimulu
applic
effect
pma
h
similar
known
molecul
mediat
bind
leukocyt
help
penetr
tissu
importantli
use
concentr
h
caus
express
increas
time
higher
hour
exposur
pma
may
indic
express
result
synergist
activ
h
sever
signal
pathway
aktpkb
mapkinas
forth
chang
express
gener
insignific
concentr
pma
h
increas
express
antigen
observ
h
combin
simultan
consequ
increas
express
surfac
antigen
ec
oxid
stress
certainli
determin
develop
vascular
dysfunct
characterist
patholog
critic
state
figur
mitot
compet
mammalian
cell
type
react
oxid
stress
factor
undergo
phenotyp
distinct
form
growth
arrest
call
cellular
senesc
endotheli
cell
chang
result
phenotyp
proinflammatori
proatherosclerot
prothrombot
two
type
cell
senesc
identifi
replic
senesc
telomer
attrit
stressinduc
prematur
senesc
without
telomer
involv
type
cell
senesc
lead
arrest
endotheli
cell
growth
loss
vascular
function
thu
contribut
develop
cardiovascular
diseas
activ
reninangiotensinaldosteron
endothelin
system
caus
endotheli
dysfunct
vascular
remodel
endotheli
senesc
induc
ro
product
promot
inflamm
cell
growth
addit
chang
express
plasma
level
import
endotheli
compon
relat
endothelialmedi
modul
hemostasi
includ
alter
metabol
nitric
oxid
prostanoid
thrombomodulin
vwf
alter
potenti
procoagul
statu
develop
age
highlight
endotheli
role
develop
thrombosi
age
demonstr
sirtuin
protect
ec
vascular
age
sequenti
parallel
senesc
chronic
oxid
stress
inflamm
influenc
insulinlik
growth
factor
ii
transform
growth
ec
may
contribut
fibrosi
process
endothelialtomesenchym
transit
endomt
figur
process
certain
subset
ec
lose
endotheli
characterist
transform
mesenchymallik
smooth
musclelik
cell
suscept
redifferenti
mesoderm
cell
type
includ
osteoblast
chondrocyt
adipocyt
initi
transcript
reprogram
led
endomttranscript
factor
slug
snail
twist
event
coupl
loss
apicalbas
polar
sever
intercellular
junction
importantli
chang
persist
remov
induc
agent
accompani
function
loss
acetyl
ldl
uptak
migratori
capac
acquisit
de
novo
collagen
synthesi
capac
still
unclear
regulatori
signal
determin
cell
undergo
complet
partial
endomt
case
sprout
angiogenesi
contactdepend
notch
signal
pathway
play
role
process
endomt
also
exist
contribut
develop
progress
cardiac
fibrosi
lung
fibrosi
liver
fibrosi
corneal
fibrosi
forth
bind
subsequ
activ
smaddepend
smadindepend
intracellular
signal
consid
import
pathway
initi
endomt
enhanc
express
caus
result
endomt
addit
synergist
stimul
endomt
induc
canon
smad
pathway
involv
hypoxia
anoth
factor
induc
endomt
via
activ
plethora
data
suggest
crucial
regulatori
molecul
endomt
level
regul
phosphoryl
phosphoryl
undergo
proteasom
degrad
play
inhibitori
role
intern
receptor
subsequ
degrad
endomt
also
modul
morphogen
pathway
includ
wnt
sonic
hh
notch
final
result
intracellular
signal
event
activ
mesenchym
cellspecif
transcript
gene
regul
program
lead
enhanc
synthesi
variou
myofibroblastspecif
profibrot
macromolecul
includ
fn
comp
mmpinhibitor
timp
simultan
repress
ecspecif
gene
product
vecadherin
vwf
occur
lead
phenotyp
convers
ec
myofibroblast
mainli
respons
fibrot
process
shown
reduc
endomt
restor
express
applic
correl
endomt
regress
contrast
express
downstream
activ
oxid
stress
signal
lead
overexpress
appear
endomt
importantli
blockad
endotheli
express
reduc
endomt
two
mirna
thu
act
respect
upstream
downstream
activ
signal
consid
major
mediat
endomt
wherea
bone
morphogenet
protein
also
known
osteogen
fibroblast
growth
factor
fgf
report
augment
oppos
endomt
specif
context
also
stimul
endotheli
autophagi
seem
promis
reduct
endomt
autophagi
induc
rapamycin
trehalos
counteract
endomt
process
trigger
decreas
phosphoryl
level
reduc
express
snail
breakthrough
discoveri
publish
demonstr
abil
cardiac
fibroblast
adopt
endothelialcelllik
phenotyp
acut
ischem
cardiac
injuri
fibroblastderiv
ec
exhibit
anatom
function
characterist
nativ
ec
induct
pathway
cardiac
fibroblast
augment
mesenchymaltoendotheli
transit
improv
circul
cardiac
function
reduc
endomt
system
sclerosisassoci
interstiti
lung
diseas
cyclophosphamid
administ
clinician
wherea
mycophenol
methotrex
use
less
sever
skin
progress
novel
agent
capabl
modul
fibrot
inflammatori
pathway
involv
system
sclerosi
pathogenesi
includ
tocilizumab
pirfenidon
tyrosin
kinas
inhibitor
lipid
lysophosphatid
acid
inhibitor
natur
compound
geniposid
iridoid
glycosid
isol
gardenia
plant
glycyrrhizin
saponin
glycyrrhiza
glabra
liquoric
root
seem
promis
geniposid
remedi
bleomycininduc
dermal
capillari
loss
fibrosi
mice
express
key
endomt
factor
slug
snail
twist
mtor
signal
pathway
mtor
also
attenu
geniposid
treatment
glycyrrhizin
significantli
amelior
dermal
fibrosi
bleomycintr
mice
partli
attribut
blockad
signal
dermal
fibroblast
downregul
thrombospondin
latent
receptor
transcript
factor
furthermor
bleomycindepend
induct
helper
type
immun
polar
macrophag
infiltr
endomt
greatli
suppress
mice
administ
glycyrrhizin
purpos
diagnost
determin
state
patient
character
chang
complex
biochem
immunolog
indic
biomark
term
biomark
gener
use
defin
indic
reflect
state
organ
result
develop
function
well
interact
bodi
extern
factor
chemic
physic
biolog
natur
biomark
defin
measur
characterist
biochem
physiolog
immunolog
individu
may
consid
risk
factor
diseas
outcom
indic
diseas
progress
treatmentassoci
chang
sharp
boundari
marker
biomark
endotheli
cell
sinc
express
surfac
cut
cell
shed
circul
ace
vwf
solubl
adhes
molecul
etc
inflamm
indic
elev
level
svcam
sicam
eselectin
along
creactiv
protein
crp
inflammatori
cytokin
ec
progenor
deriv
biomark
per
se
normal
popul
endotheli
progenitor
cell
epc
high
wherea
level
endotheli
microparticl
emp
circul
endotheli
cell
cec
indic
endotheli
damagear
low
emp
circul
submicrons
vesicl
origin
damag
ec
variou
biolog
function
shown
act
primari
secondari
messeng
vascular
inflamm
thrombosi
vasomotor
respons
angiogenesi
endotheli
surviv
emp
emerg
biomark
dysfunct
endothelium
wherebi
differenti
presenc
emp
link
diseas
manifest
phenotyp
characterist
dysfunct
endothelium
includ
impair
vasodil
increas
lipid
peroxid
uric
acid
nitrotyrosin
procoagul
proinflammatori
phenotyp
decreas
vascular
repair
capac
increas
number
emp
cec
howev
exampl
endotheli
biomark
deserv
special
consider
transaminas
tradit
consid
marker
liver
heart
contribut
endothelium
blood
level
rather
obscur
ischemiareperfus
injuri
endotheli
permeabl
increas
togeth
neutrophil
sequestr
rise
blood
transaminas
activ
macrophag
gener
signific
amount
caus
damag
lung
tissu
also
coupl
elev
level
transaminas
blood
signific
clarif
impact
endothelium
dynam
blood
transaminas
made
studi
mediterranean
spot
fever
also
known
marseil
fever
boutonneus
fever
infect
patient
elev
level
transaminas
norm
observ
blood
usual
associ
damag
liver
heart
patient
increas
level
transaminas
liver
spleen
also
regist
despit
fact
chronic
liver
heart
diseas
could
sourc
transaminas
experi
infect
ec
rickettsia
conorii
bacterium
marseil
fever
show
signific
increas
transaminas
supernat
along
specif
endotheli
marker
interest
note
elev
level
triglycerid
apob
transferas
alkalin
phosphatas
low
level
cholesterol
apoa
blood
platelet
also
observ
patient
wherea
bilirubin
albumin
normal
level
indic
state
liver
normal
though
state
endothelium
compromis
endothelium
site
action
three
princip
lipas
lipoprotein
lipas
hepat
lipas
endotheli
cell
lipas
play
central
role
triglycerid
phospholipid
hydrolysi
note
transferas
alkalin
phosphatas
also
biomark
endotheli
damag
heart
stroke
elev
transaminas
togeth
classic
endotheli
marker
endothelin
vwf
decreas
level
ace
observ
system
inflammatori
diseas
usual
coupl
elev
level
biomark
endotheli
injuri
togeth
biomark
dysfunct
variou
organ
howev
due
lack
investig
cover
biochem
paramet
blood
one
conclud
specif
import
indic
much
complex
obscur
role
endothelium
develop
effect
chronic
acut
exposur
toxic
agent
notabl
organophosph
op
nerv
agent
neuron
neuromuscular
synaps
also
ec
mani
sign
autonom
cholinerg
regul
due
muscarin
receptor
ec
becam
famou
site
gener
endotheliumdepend
relax
factor
edrf
later
reveal
nitric
oxid
howev
ncholinoceptor
also
found
well
activ
acetylcholinesteras
ach
cholinacetyl
transferas
provid
synthesi
acetylcholin
vesicular
system
acetylcholin
transport
cell
spite
recent
advanc
therapeut
treatment
op
poison
usual
proceed
predomin
heavi
cholinerg
crisi
even
case
surviv
victim
delay
patholog
often
observ
socal
intermedi
syndrom
opinduc
distal
sensorimotor
axonophati
symptom
veget
chang
circulatori
system
cn
microorgan
disord
unknown
ethiolog
forth
ach
main
target
op
principl
exist
therapi
acut
poison
converg
elimin
effect
ach
inhibit
op
administr
cholinolyt
eg
atropin
reactiv
ach
oxim
anticonvuls
drug
agonist
gabaand
antagonist
glutam
receptor
prevent
mean
alleg
poison
revers
ach
inhibitor
use
eg
pyridostigmin
mechanist
studi
reduc
reveal
interact
op
molecular
target
nerv
cell
thu
estim
op
interact
coval
bind
tyrosin
residu
tubulin
opbind
site
disloc
near
gtpbind
site
within
loop
interact
protofila
could
partli
explain
decay
fast
axon
transport
neurophysiolog
effect
chronic
exposur
op
paper
report
influenc
op
endothelium
experiment
model
mice
examin
pulmonari
effect
strimethyl
phosphorothio
oostmp
injuri
ec
accompani
signific
enhanc
wet
lung
weight
percentag
lung
water
content
anoth
studi
chlorpyrifo
wide
concentr
rang
show
effect
isol
thorac
aorta
though
plasma
ach
activ
decreas
ldh
alt
ggt
ast
activ
togeth
plasma
level
increas
chlorpyrifo
group
studi
also
paid
attent
damag
vascular
endothelium
develop
opinduc
delay
patholog
first
suggest
thrombot
microangiopath
disord
result
endotheli
damag
could
primari
reason
develop
delay
effect
op
intox
signific
kind
disord
reestim
recent
year
interrel
neural
blood
flow
neuromuscular
conduct
great
interest
take
consider
low
percentag
endoneur
capillari
clue
depend
trophism
nerv
fibr
upon
vasculatur
come
follow
data
volum
capillari
exceed
total
volum
nerv
fibr
addit
lymphat
vessel
within
peripher
nerv
could
provid
effect
outflow
capillari
infiltr
prevent
develop
edema
earlier
suggest
role
nonsynapt
blood
vesseldepend
mechan
delay
effect
acut
subchron
influenc
op
sever
week
exposur
op
found
angiodiston
disturb
new
open
preexist
arterioven
anastomos
dilat
diston
venul
within
endoneurium
sciatic
nerv
mesenterium
small
intestin
figur
morpholog
sign
accompani
function
one
norepinephrineinduc
contract
carbacholinduc
relax
rat
aorta
subchron
month
exposur
paraoxon
dfp
dose
month
rehabilit
period
figur
morpholog
function
chang
microvessel
affect
function
state
platelet
creat
etiolog
delay
effect
acut
subchron
toxic
observ
chang
reflect
multipl
microangiopathi
obviou
clinic
sign
often
seen
due
variou
compensatori
mechan
msm
analysi
blood
plasma
anim
intox
rvx
reveal
fragment
fibrinopeptid
signifi
exposur
rvx
caus
inactiv
reduc
express
exopeptidas
aminopeptidas
variou
aminopeptidas
known
function
blood
plasma
vascular
bed
could
respons
effect
aminopeptidas
lalphaaspartyl
lalphaglutamyl
peptid
hydrolas
ec
hydrolys
acid
amino
acid
asp
glu
fragment
fibrinopeptid
aminopeptidas
n
ec
multifunct
enzym
princip
aminopeptidas
circul
express
cell
myeloid
origin
includ
monocyt
neutrophil
also
found
fibroblast
epitheli
endotheli
cell
angiogen
growth
signal
factor
shown
increas
express
hand
alphastatin
acid
peptid
deriv
amino
terminu
human
fibrinogen
possess
antiangiogen
activ
previous
reveal
fibrinogen
degrad
product
e
mani
proteolyt
degrad
product
also
reveal
endogen
inhibitor
angiogenesi
endotheli
biomark
biomark
use
ideal
use
quantit
evalu
bodi
respons
extern
effect
quantit
characterist
includ
diagnost
sensit
specif
predict
valu
likelihood
ratio
forth
ideal
biomark
character
high
sensit
specif
predict
valu
reproduc
human
differ
sex
ethnic
group
procedur
determin
costeffect
howev
rare
marker
stand
alon
singl
paramet
rather
deriv
sever
origin
indic
time
complex
physiolog
biochem
method
combin
appropri
analyt
platform
rel
simpl
lowinvas
noninvas
method
univers
modular
flexibl
algorithm
ambigu
express
pattern
complex
determin
mani
biomark
decreas
predict
valu
lead
overdu
diagnosi
bad
prognosi
parallel
measur
multipl
earli
biomark
would
certainli
increas
diagnost
accuraci
togeth
identif
studi
valid
studi
multimark
assay
urgent
need
biopsi
gold
standard
diagnos
mani
chronic
diseas
though
morpholog
method
common
tool
clinic
diagnost
due
invas
techniqu
suitabl
continu
monitor
moreov
mani
diseas
may
morpholog
analog
gold
standard
necessit
perman
expans
function
pointofcar
diagnost
clinic
practic
search
safe
reliabl
inexpens
method
result
exampl
develop
larg
number
biomark
noninvas
assess
liver
fibrosi
repres
simpl
directli
measur
paramet
deriv
indic
ratio
increas
sensit
andor
specif
assess
diagnosi
ratio
level
ast
level
altth
socal
de
riti
ratio
ratio
ast
number
platelet
pga
indexth
ratio
prothrombin
time
level
ggt
apolipoprotein
pga
index
later
modifi
due
becam
known
pgaa
index
fibrotest
known
fibrosur
us
includ
apolipoprotein
ggt
haptoglobin
total
bilirubin
recent
report
new
screen
indic
biomark
health
assess
personnel
chemic
weapon
destruct
facil
cwdf
blood
plasma
healthi
donor
cwdf
personnel
occupi
differ
facil
workshop
zone
analys
cytokin
signific
elev
eotaxin
concentr
reveal
blood
plasma
dirti
zone
personnel
screen
assess
health
state
personnel
new
complex
biomark
suggest
relat
eotaxin
capabl
differenti
dirti
zone
personnel
other
sensit
specif
differ
control
group
personnel
occupi
clear
condit
dirti
zone
cwdf
much
greater
compar
wellknown
popular
index
character
balanc
thelper
importantli
subject
directli
influenc
level
produc
ec
wherea
influenc
level
produc
monocyt
signific
increas
index
sign
reciproc
even
ontolog
relat
eotaxin
provid
synergist
effect
diagnost
combin
marker
defin
combinatori
biomark
whose
identif
usual
involv
multivari
assay
combinatori
biomark
provid
specif
pattern
bear
much
inform
individu
marker
detect
pattern
requir
complex
bioinformat
analysi
necessari
multidimension
data
howev
express
biomark
well
prognost
predict
valu
combin
need
welldefin
howev
even
search
process
present
great
difficulti
deal
highdimension
dataset
huge
number
paramet
exampl
approach
research
neurolog
relat
biochem
diagnosi
cerebrovascular
disord
diagnos
particular
subtyp
stroke
assess
sever
predict
possibl
develop
probabl
lethal
success
outcom
biochem
criteria
variou
author
attempt
simultan
measur
indic
search
correl
ultim
set
compris
four
five
reliabl
indic
marker
found
taken
togeth
provid
sensit
specif
strategi
studi
combin
sensit
tissuespecif
marker
least
one
marker
specif
cn
use
nonspecif
marker
requir
order
increas
sensit
complex
test
biochem
test
undeni
fundament
advantag
complex
instrument
method
diagnost
perform
pointofcar
test
one
field
search
new
biomark
metabolom
metabolom
end
product
genom
fact
total
metabolit
predominantli
low
molecular
weight
metabolit
final
intermedi
product
metabol
live
system
biolog
matric
character
function
mode
epistemolog
classif
transcriptom
total
mrna
proteom
total
protein
place
genom
metabolom
studi
metabolom
howev
suffici
reward
firstli
major
metabol
pathway
fairli
well
studi
exist
major
metabolit
well
known
secondli
total
number
metabolit
rel
small
compar
total
number
modifi
protein
note
metabolom
deal
biomark
eg
metabolit
endogen
origin
toxicolog
pharmacolog
studi
metabolit
divid
endogen
exogen
metabolit
foreign
substanc
drug
poison
etc
call
xenometabolit
xenobiot
field
studi
anoth
termmetabonom
altern
biomark
divid
three
categori
biomark
exposur
concentr
chemic
adduct
deriv
bodi
fluid
tissu
result
extern
intern
exposur
biomark
effect
earli
delay
biochem
clinic
effect
biomark
suscept
individu
increas
sensit
toward
target
molecul
main
method
metabolom
nuclear
magnet
reson
spectroscopi
nmr
differ
nuclei
h
c
p
etc
ga
chromatographymass
spectrometri
gcm
nmr
spectroscopi
use
detect
low
molecular
weight
metabolit
blood
urin
serum
tissu
advantag
nmr
simplic
sampl
prepar
spectrum
interpret
well
high
perform
main
drawback
nmr
low
sensit
suffici
determin
metabolit
whose
concentr
rel
high
highperform
liquid
chromatographi
massselect
detect
hplcm
much
sensit
low
molecular
weight
da
metabolit
even
peptid
precis
make
possibl
accur
identifi
mani
peptid
nucleosid
even
complex
matric
howev
hplcm
mani
limit
detect
low
molecular
weight
compound
exampl
fatti
acid
essenti
compon
metabol
primari
data
process
use
hierarch
multivari
curv
resolut
multivari
profil
includ
princip
compon
analysi
pca
orthogon
project
latent
structur
opl
partial
least
squar
discrimin
analysi
plsda
method
part
chemometr
independ
scientif
direct
origin
intersect
mathemat
informat
analyt
chemistri
import
emphas
method
metabolom
intend
replac
method
classic
biochemistri
spectrophotometri
enzym
immunoassay
etc
metabol
profil
provid
uniqu
opportun
perform
diagnos
monitor
qualit
new
level
conjunct
method
biochem
analysi
recent
studi
influenc
chronic
exposur
low
dose
c
c
aliphat
hydrocarbon
metabol
profil
rat
investig
use
gcm
highresolut
lcm
chemometr
algorithm
appli
combinatori
biomark
deriv
ratio
concentr
pyrophosph
oxal
blood
plasma
found
sensit
biomark
call
pyrophosph
index
whose
chang
statist
signific
group
even
expos
lowest
dose
mgm
analys
broad
rang
metabolit
came
conclus
increas
level
blood
plasma
evid
caus
decreas
level
andor
activ
tissuenonspecif
alkalin
phosphatas
tnap
marker
bbb
endotheli
cell
indic
risk
hypophosphatasia
neurolog
disord
includ
epilepsi
disrupt
myelin
synthesi
also
coupl
increas
phosphoryl
tau
protein
upregul
phosphoryl
fatti
acid
translocas
addit
anoth
import
index
reveal
elev
hypotaurintaurin
indic
abnorm
mechan
util
cy
may
lead
deficit
glutathion
sinc
cy
sourc
hypotaurin
glutathion
moreov
analys
broad
rang
relat
metabolit
suggest
redox
hypothesi
pathogenesi
toxic
polyneuropathi
altern
longestablish
energi
hypothesi
redox
hypothesi
cover
energi
aspect
also
impli
violat
interfac
energet
signal
metabol
process
sens
conform
principl
orthogon
regul
signal
metabol
process
live
cell
includ
endotheli
one
seem
endothelium
due
difus
strateg
posit
provid
orthogon
control
state
name
morphofunct
state
organ
andor
tissu
eg
neural
endothelium
strateg
locat
interfac
blood
interstiti
tissu
ec
exist
dynam
equilibrium
environ
constitut
simultan
sourc
barrier
target
defens
mediat
therapeut
intervent
rule
vascular
patholog
caus
multipl
factor
involv
genet
environment
one
wherea
current
clinic
treatment
mostli
target
individu
molecul
involv
pathophysiolog
pathway
approach
genotyp
phenotyp
studi
govern
onegeneonephenotyp
hypothesi
time
scienc
move
ahead
combin
genom
proteom
metabolom
describ
origin
etiolog
essenc
pathophysiolog
vasculardepend
patholog
bigdata
fashion
also
reveal
new
unrival
relationship
omic
variabl
restrict
definit
clinic
phenotyp
vascular
diseas
phenom
strategi
announc
two
decad
ago
gradual
chang
convent
phenotypegenotypegenom
approach
new
systemat
phenomegenomeproteom
studi
phenom
whole
set
organ
phenotyp
trait
result
express
genom
specif
environment
influenc
phenom
novel
approach
quantit
correl
multipl
phenotyp
trait
variabl
transcriptom
proteom
metabolom
interactom
environment
factor
togeth
genom
develop
phenom
defin
set
biomark
diagnosi
vascular
patholog
also
reveal
novel
target
combin
therapi
well
novel
test
system
animalfre
chemic
safeti
assess
thu
make
revolutionari
paradigm
shift
preclin
test
drug
clinic
treatment
devast
diseas
parallel
similar
concept
toxicometabolom
develop
known
toxic
pathway
toxic
signatur
toxicometabolom
intend
integr
understand
toxicokinet
chemic
toxicodynam
physiolog
biochem
respons
toxic
effect
well
specifi
concept
homeostasi
stress
mechan
adapt
effect
foreign
chemic
compound
result
integr
complet
map
toxic
pathway
creat
toxom
holist
understand
mechan
action
substanc
relationship
dose
time
consequ
exposur
two
scientif
direct
almost
readi
converg
due
develop
common
algorithm
comput
model
tool
interestingli
comput
collabor
differ
institut
consid
one
difficult
problem
exist
approach
manag
grow
volum
heterogen
data
provid
adequ
comput
environ
consist
scientif
analysi
endotheli
interfac
tissu
ro
interfac
cell
repres
two
princip
boundari
cellular
molecular
respect
integr
interior
exterior
live
bodi
evid
ro
gener
h
particular
serv
trigger
system
ec
cell
provid
ca
depend
regul
metabol
row
auxiliari
molecul
channel
break
signal
metabol
pathway
ro
implement
orthogon
regul
metabol
modul
kinet
characterist
biochem
reaction
redox
modul
specif
local
depend
size
redox
potenti
ro
oxid
electrophil
concentr
avail
target
consist
mainli
amino
acid
import
note
socal
antioxid
perhap
ambigu
specul
group
dietari
supplement
vitamin
c
e
use
mani
peopl
believ
high
dosag
antioxid
improv
health
resist
diseas
assumpt
howev
gener
support
scientif
data
antioxid
supplement
demonstr
exert
advers
effect
especi
adapt
intens
train
antioxid
actual
reduc
level
oxid
stress
molecul
though
improv
often
correl
adapt
strenuou
exercis
mani
antioxidantbas
clinic
trial
therapeut
intervent
larg
disappoint
therapeut
benefit
time
natur
metabolit
pyruv
ethylpyruv
etc
nutraceut
taken
exogen
food
addit
separ
effect
neutral
oxid
stress
improv
health
even
enhanc
adapt
physic
stress
import
prerequisit
new
concept
redox
biologymedicin
use
compound
term
patholog
activ
therapeut
rel
small
molecul
chemic
convert
activ
form
oxid
stress
intend
combat
sulfid
disulfid
organosulfur
compound
osc
wide
present
bodi
natur
environ
interact
neutral
ro
determin
thioldisulfid
redox
state
signal
sens
thu
maintain
bodi
healthi
contribut
develop
diseas
hand
protein
readili
form
redox
state
cell
insuffici
oxid
famou
jame
watson
even
suggest
type
diabet
redox
diseas
could
treat
moder
physic
exercis
exercis
train
optim
redox
environ
enhanc
capac
cell
neutral
ro
disulfid
bridg
form
posttransl
modif
protein
highli
import
keep
tertiari
structur
maintain
function
activ
disulfid
bond
format
possibl
due
oxid
potenti
exist
specif
cellular
compart
wittili
note
bardwel
longrun
race
find
sourc
oxid
potenti
disulfid
bond
format
winner
one
first
contest
enter
oxygen
nevertheless
oxygen
alway
avail
plenti
amount
exampl
ischem
state
case
artifici
natur
electrophil
electron
acceptor
could
help
properti
exploit
elabor
new
type
therapeut
help
osc
polyphenol
nutraceut
nutraceut
could
serv
electrophil
also
kind
proelectrophil
drug
becom
electrophil
respons
oxid
subsequ
activ
transcript
pathway
synthesi
endogen
antioxid
phase
enzym
mani
nutraceut
multipl
molecular
function
target
human
anim
least
two
consequ
follow
fact
experiment
anim
vitro
studi
hardli
overestim
studi
nutraceut
base
multitarget
drug
approach
accord
focu
place
select
molecular
target
judg
relev
estim
safeti
concern
exampl
mani
natur
product
agonist
andor
bioactiv
pattern
activ
compound
plant
extract
warrant
futur
research
regard
therapeut
potenti
possibl
modul
activ
dietari
intervent
food
supplement
research
consid
osc
ideal
nutraceut
agent
serv
direct
antioxid
trap
electron
also
nonantioxid
effect
antiplatelet
fibrinolyt
antiinflammatori
immunomodulatori
antiag
action
forth
present
diet
qualiti
indic
embrac
overal
diet
qualiti
contrast
singl
nutrient
draw
increas
attent
especi
relev
state
endothelium
vascular
diseas
strong
associ
food
pattern
fp
endotheli
biomark
healthi
fp
higher
intak
fruit
veget
benefici
effect
endotheli
function
estim
level
biomark
crp
eselectin
molecul
westernis
fp
abund
meat
sweet
fri
food
refin
grain
correl
biomark
inflamm
atherogenesi
apart
food
contrast
abovement
antioxid
moder
aerob
exercis
posit
affect
redox
state
biomark
cognit
abil
older
adult
consid
anoth
complic
problem
peripher
neuropathi
among
prevail
neurolog
condit
encount
physician
toxicologist
three
distinct
challeng
physician
care
patient
peripher
neuropathi
effici
effect
screen
patient
peripher
neuropathi
clinic
stratifi
patient
treat
symptom
limit
studi
design
togeth
larg
variabl
surrog
marker
vascular
tissu
damag
reduc
strength
evid
base
microvascular
lesion
diabet
peripher
arteri
diseas
still
resolv
current
surgic
intervent
techniqu
though
ec
therapeut
potenti
cure
microvascular
lesion
rather
exquisit
elabor
transcathet
arteri
infus
autolog
cell
one
obstacl
affect
process
stem
cell
retreiv
elderi
patient
tend
presenesc
alreadi
senesc
therefor
vitro
manipul
caus
age
stem
cell
undergo
massiv
vivo
apoptosi
transplant
time
endotheli
progenitor
mobil
noninvas
techniqu
ye
nutraceut
stemkin
complex
augment
hemopoiet
endotheli
progenitor
next
day
begin
administr
moreov
moder
exercis
actual
improv
vascular
function
patient
type
diabet
thu
give
us
confid
elabor
natur
approach
solv
problem
vascular
health
diseas
final
feel
oblig
offer
advic
tri
order
prevent
even
cure
diseas
need
repair
blood
vessel
advanc
parallel
need
first
acquir
adequ
inform
adequ
diagnost
would
compris
monitor
state
endothelium
specif
markersbiomark
inter
alia
would
help
complet
remov
damag
factor
need
appli
natur
mean
nutraceut
physic
activ
would
help
stop
flow
complet
tune
kinet
harmon
metabol
signal
pathway
due
soft
power
influenc
two
princip
interfac
endotheli
cell
throughout
bodi
ro
signal
mani
cell
throughout
bodi
advis
extern
consumpt
essens
perspect
scienc
someth
rotten
state
one
differ
sens
outsid
insid
state
suppli
adequ
inform
sometim
simpli
mass
media
greatli
help
peopl
ration
exploit
natur
materi
financi
resourc
state
accord
place
earth
histori
cultur
cheap
cheer
applic
nutraceut
physic
activ
cure
rotten
state
endothelium
would
greatli
help
tissu
organ
accord
place
bodi
ontogenet
featur
function
trait
cheap
cheer
alphasmooth
muscl
actin
ace
angiotensinconvert
enzym
ach
acetylcholinesteras
ad
alzheim
diseas
alt
alanin
transaminas
angpt
angiopoietin
ang
angiotensin
ast
aspart
transaminas
bbb
bloodbrain
barrier
bone
morphogenet
protein
cam
cell
adhes
molecul
cec
circul
endotheli
cell
cn
central
nervou
system
crp
creactiv
protein
cvd
cardiovascular
diseas
cwdf
chemic
weapon
destruct
facil
dag
diacylglycerol
dfp
diisopropyl
fluorophosph
diacylglycerol
kinas
alpha
ec
endotheli
cell
edrf
endotheliumdepend
relax
factor
egf
epiderm
growth
factor
emp
endotheli
microparticl
endomt
endothelialtomesenchym
transit
epc
endotheli
progenitor
cell
er
endoplasm
reticulum
fat
fatti
acid
translocas
fgf
fibroblast
growth
factor
fp
food
pattern
ggt
transferas
gsk
glycogen
synthas
kinas
hypoxiainduc
huvec
human
umbil
vein
endotheli
cell
icam
intercellular
adhes
molecul
ig
immunoglobulin
ldh
lactat
dehydrogenas
ldl
lowdens
lipoprotein
lymphocyt
functionassoci
antigen
mapk
mitogenactiv
protein
kinas
mtor
mechanist
target
rapamycin
no
synthas
nox
nadph
oxidas
osteogen
op
organophosph
osc
organosulfur
compound
oxldl
oxid
lowdens
lipoprotein
pa
phosphatid
acid
platelet
ec
adhes
peroxisom
proliferatoractiv
receptor
coactiv
phosphoinositid
pkc
protein
kinas
c
pma
phorbol
peroxisom
proliferatoractiv
receptor
prx
peroxiredoxin
ptk
protein
tyrosin
kinas
ra
reninangiotensin
system
rfk
riboflavin
kinas
ro
reactiv
oxygen
speci
sirt
sirtuin
sod
superoxid
dismutas
transform
growth
tnap
tissuenonspecif
alkalin
phosphatas
tumor
necrosi
factor
alpha
tpa
tissu
plasminogen
activ
trp
transient
receptor
potenti
vecadherin
vascular
endotheli
cadherin
vegf
vascular
endotheli
growth
factor
vegfr
vegf
receptor
veptp
vascular
endotheli
protein
tyrosin
phosphatas
vvo
vesiculovacuolar
organel
vwd
vwf
diseas
vwf
von
willibrand
factor
author
confirm
conflict
interest
